Antimicrobial Resistance Articles & Analysis
59 news found
“Klebsiella bacteria have increasingly developed antimicrobial resistance, including to the class of antibiotics known as carbapenems,” said Derrick A. ...
Bacteria are present in large numbers in livestock buildings, and can threaten animal and public health. Antimicrobial resistance (AMR) is a major concern worldwide, and national measures based on the “One Health” approach are being implemented in many countries. However, very little is known about the risk of AMR in livestock barn aerosols, and in ...
The agency warns Klebsiella bacteria have increasingly developed antimicrobial resistance, most recently to the class of antibiotics known as carbapenems. ...
An article published last year in Emerging Infectious Diseases detailed a notable increase of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections in New York City during 2021 through June of 2022. ...
“The Centers for Disease Control and Prevention (CDC) warns that increasingly, Klebsiella bacteria have developed antimicrobial resistance, most recently to the class of antibiotics known as carbapenems. ...
The Food Safety Authority (EFSA or FDA) requires critical plasmid information for the food or feed industry, mainly because of the spread of antibiotic resistance traits. CD Genomics has developed a unique sequencing-based platform to help researchers rapidly and effectively identify and characterize plasmids. ...
Dr Michael Craig, (Director of Antimicrobial Resistance) at the US CDC stated: “Decolonization is something that is very important to us at CDC and something that we think really holds a lot of potential in terms of saving lives and importantly addressing the challenges of antimicrobial resistance that we face, not only ...
This preventative approach will allow Lumen to develop an inexpensive, biologic drug cocktail against the most frequent, multi-drug resistant infecting pathogens. The therapeutic product would be administered and be designed to mitigate risks of antibiotic-resistant infections in resource constrained settings such as battlefield medicine and trauma care. ...
The company launches the drug-resistant metabolomics research service for oncology research and infectious disease studies regarding drug resistance. ...
The XF-73 Dermal product is planned to be a fast, cost-effective dermal treatment that kills all relevant bacteria quickly, helping the wound heal and combatting the threat of Antimicrobial Resistance (AMR) through its novel, patented action. Destiny Pharma will continue to work with NIAID to complete this preclinical safety package which will support future ...
(LON: OBI), this week presented an in vitro study at the World Anti-Microbial Resistance Congress, in Maryland, USA on the effectiveness of its photodisinfection technology against the group of highly infectious and antibiotic-resistant bacteria known as ESKAPE ...
With only a few antibiotics in clinical development, new technologies, especially ones that do not develop antimicrobial resistance, are needed to treat healthcare-associated infections. ...
The availability of this innovative test provides a valuable tool in the growing global threat posed by antimicrobial resistance (AMR). According to the World Health Organization, AMR is in fact, one of the top 10 global public health threats for humanity and it is estimated to kill 700,000 people a year worldwide, 33,000 across the EU alone. ...
ByMeMed
Through its unique bacteriophage discovery, synthetic biology, and manufacturing platform, Locus is developing two innovative categories of biotherapeutics to address significant unmet medical needs: precision CRISPR-enhanced bacteriophage (crPhage®) products to fight deadly infections, including those caused by multi-drug resistant bacteria; and engineered bacteriophage ...
“Building on scientific and clinical data from our SER-109 program, we are encouraged by these preclinical findings that bolster our confidence in combating additional important infectious diseases and the continued threat of antimicrobial resistance with further development of SER-155 as a potentially transformative new ...
The need for Rapid AST testing in the US is clear and early interest has been overwhelming. With the trajectory of antimicrobial resistance and sepsis, labs need access to a fast, scalable Rapid AST system with broad antibiotic panels. ...
Preclinical activities are also underway for additional Infection Protection development candidates, leveraging our prior compelling clinical data in this therapeutic category, for indications such as cancer neutropenia, solid organ transplant, and antimicrobial resistant infections more broadly,” continued Mr. Shaff. ...
(Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced today that its subsidiary, Ares Genetics (“Ares”), which strives to become a leader in bacterial genomics and AI-powered prediction of antimicrobial resistance (AMR), is ...
(Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced today that its subsidiary, Ares Genetics (Ares), which strives to become a leader in bacterial genomics and AI-powered prediction of antimicrobial resistance (AMR), is expanding its strategic ...
From rapid treatment and combating antimicrobial resistance, to providing personalized medicine, the need for clinical diagnostics, especially in vitro diagnostics, continues to expand. ...